Coronavirus (COVID-19) AstraZeneca vaccine (ChAdOx1-S [Recombinant]): national protocol v3.0

This protocol is for the supply and administration of AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) to individuals in accordance with the national COVID-19 vaccination programme. This protocol only allows supply and administration during or in anticipation of the COVID-19 pandemic.

This document is part of a collection

AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) Vaccine National Protocol

Reference no: AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) Vaccine Protocol

Version no: v 3.0

Valid from: 02 February 2021

Review date: 30 November 2021

Expiry date: 31 December 2021



Back to top